Call for Papers   a href="https://bentham.manuscriptpoint.com/journals/acamc" class="submit_manuscript">Call for Papers  

Article Details


MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53

[ Vol. 23 , Issue. 16 ]

Author(s):

Yu-Sheng Wang, Ji-Zhong Yin, Xiao-Qian Shi, Xue-Wei Zhao, Bing Li* and Meng-Hang Yang*   Pages 1829 - 1837 ( 9 )

Abstract:


<p>Introduction: Small cell lung cancer (SCLC) is featured by a high TP53 mutant rate. Our previous research found that arsenic trioxide (As<sub>2</sub>O<sub>3</sub>) could significantly inhibit the growth and metastasis of SCLC. Studies have shown that the degradation of mutant p53 mediated by murine double minute 2 (MDM2) can be induced by As<sub>2</sub>O<sub>3</sub>, which probably contributes to the inhibition of SCLC, but the detailed mechanism is still unclear. We aimed to testify that As<sub>2</sub>O<sub>3</sub> can inhibit the growth of SCLC cells by degrading mutant p53 protein via binding to MDM2. </p><p> Methods: CCK-8 assay, cell cycle analysis, and western blot of apoptosis markers were used to evaluate the inhibitory effect of As<sub>2</sub>O<sub>3</sub> on NCI-H446 cells (containing mutant p53) and NCI-H1299 cells (p53 null). The effects of As<sub>2</sub>O<sub>3</sub> on p53 and its downstream proteins were identified by western blot using mut-p53-knockdown and overexpressed cell models. MDM2-knockdown cell models were constructed, and western blot, co-IP of mut-p53, and ubiquitin were carried out to explore the mediating effect of MDM2 in As<sub>2</sub>O<sub>3</sub> induced mut-p53 degradation. </p><p> Results: As<sub>2</sub>O<sub>3</sub> inhibited proliferation and induced cell cycle arrest and apoptosis of SCLC cells in a dose- and timedependent manner. After mut-p53 knockdown or overexpressed, the inhibitory effect of As<sub>2</sub>O<sub>3</sub> was dampened or enhanced. Additionally, As<sub>2</sub>O<sub>3</sub>-induced mut-p53 ubiquitination was significantly weakened after MDM2 knockdown. </p><p> Conclusion: As<sub>2</sub>O<sub>3</sub> could inhibit SCLC cells by inhibiting proliferation and inducing cell cycle arrest and apoptosis. These inhibitory effects were achieved at least in part by upregulating MDM2, which, in turn, promotes ubiquitination and degradation of mut-p53.</p>

Keywords:

Arsenic trioxide, small cell lung cancer, p53, MDM2, SCLC, As<sub>2</sub>O<sub>3</sub>.

Affiliation:

Graphical Abstract:



Read Full-Text article